Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 108, Issue 7, Pages 1449-1459
Publisher
Springer Nature
Online
2013-03-20
DOI
10.1038/bjc.2013.102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD24 controls Src/STAT3 activity in human tumors
- (2012) Niko P. Bretz et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
- (2012) Appalaraju Jaggupilli et al. Clinical & Developmental Immunology
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- Monoclonal antibodies for the treatment of cancer
- (2012) Casey W. Shuptrine et al. SEMINARS IN CANCER BIOLOGY
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization
- (2011) J. B. Overdevest et al. CANCER RESEARCH
- CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion
- (2011) Petra Baumann et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion
- (2011) Niko Bretz et al. CLINICAL & EXPERIMENTAL METASTASIS
- Contractile Forces Contribute to Increased Glycosylphosphatidylinositol-anchored Receptor CD24-facilitated Cancer Cell Invasion
- (2011) Claudia Tanja Mierke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody-based therapeutics to watch in 2011
- (2011) Janice M. Reichert mAbs
- Therapeutic Antibodies to Human L1CAM: Functional Characterization and Application in a Mouse Model for Ovarian Carcinoma
- (2010) S. Wolterink et al. CANCER RESEARCH
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- An Immunoconjugate of Anti-CD24 and Pseudomonas Exotoxin Selectively Kills Human Colorectal Tumors in Mice
- (2010) Shiran Shapira et al. GASTROENTEROLOGY
- Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis
- (2010) Glen Kristiansen et al. LABORATORY INVESTIGATION
- CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation
- (2009) Weifei Wang et al. CANCER SCIENCE
- Targeting CD24 for treatment of ovarian cancer by short hairpin RNA
- (2009) Dan Su et al. CYTOTHERAPY
- CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer
- (2009) M A H Ahmed et al. JOURNAL OF CLINICAL PATHOLOGY
- Cancer stem cells: markers or biomarkers?
- (2008) Wendy A. Woodward et al. CANCER AND METASTASIS REVIEWS
- Targeting CD24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA
- (2008) E. Sagiv et al. CANCER RESEARCH
- Molecular engineering and design of therapeutic antibodies
- (2008) Leonard G Presta CURRENT OPINION IN IMMUNOLOGY
- CD24 induces localization of β1 integrin to lipid raft domains
- (2007) Steffen Runz et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started